Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 251-300 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT07218848
ProSalud in Latinos Living in Rural/Agricultural Communities Within Moffitt's Catchment Area
NARecruiting
50 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2026
1 condition1 sponsor2 locations
NCT07218991
Wearable Echolocation Aids Using Parametric Sound
NARecruiting
50 participants
Started: Oct 31, 2025 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT07218952
Radiation Therapy (RT) for Parkinson's Disease (PD)
NARecruiting
20 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT07218432
A Study of the TheraBionic P1 Device in Breast Cancer
NARecruiting
24 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2028
5 conditions1 sponsor1 location
NCT07218640
Aimmune Longitudinal Collaboration Study
NARecruiting
60 participants
Started: Oct 31, 2025 · Completed: Jul 31, 2026
4 conditions1 sponsor2 locations
NCT07218731
Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses
NARecruiting
30 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT06879652
The Effect of Dairy Intake on Body Weight and Composition and Metabolic Health in Adolescents and Seniors
NARecruiting
240 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2028
3 conditions1 sponsor2 locations
NCT07173088
Efficacy and Clinical Feasibility of the Ankle Muscle Power (AMP) Program for Return to Duty After an Ankle Fracture
NARecruiting
60 participants
Started: Oct 31, 2025 · Completed: Mar 31, 2028
1 condition1 sponsor1 location
NCT06427603
Sit Less and Move More: Feasibility Study
NARecruiting
30 participants
Started: Oct 31, 2025 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT07167277
The Impact of Whey Protein on Frailty in Older Adults Classified as Pre-frail
NARecruiting
20 participants
Started: Oct 31, 2025 · Completed: Feb 28, 2026
6 conditions1 sponsor1 location
NCT06712745
Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung
EARLY_PHASE1Recruiting
30 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2028
2 conditions2 sponsors1 location
NCT07167537
A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases
PHASE1Recruiting
44 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2028
2 conditions2 sponsors1 location
NCT06836752
Effects of Yoghurt Consumption on Glucose Metabolism in Prediabetic Subjects
NARecruiting
60 participants
Started: Oct 31, 2025 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT06930846
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
NARecruiting
125 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2028
12 conditions5 sponsors1 location
NCT07093528
A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
N/ARecruiting
25 participants
Started: Oct 31, 2025 · Completed: Aug 31, 2027
2 conditions1 sponsor1 location
NCT07036705
Optimizing an Integrated Mind and Body Treatment for Insomnia: The SLEEPS Study 2
NARecruiting
40 participants
Started: Oct 31, 2025 · Completed: Jul 31, 2027
1 condition2 sponsors1 location
NCT06623240
HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis
PHASE2Recruiting
66 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06948214
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
PHASE3Recruiting
150 participants
Started: Oct 31, 2025 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT05706116
Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults
PHASE1Recruiting
18 participants
Started: Oct 31, 2025 · Completed: Apr 30, 2028
3 conditions2 sponsors2 locations
NCT06888193
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
PHASE1Recruiting
20 participants
Started: Oct 31, 2025 · Completed: May 3, 2027
4 conditions1 sponsor1 location
NCT07196514
Effects of 8 Weeks of Turmeric Ingestion on Physiology and Wellbeing in Healthy Older Adults
NARecruiting
80 participants
Started: Oct 31, 2025 · Completed: Jul 31, 2026
2 conditions2 sponsors1 location
NCT07115628
Accelerated TMS for Treatment-Resistant ECT
NARecruiting
200 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT06904261
A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
PHASE3Recruiting
8 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2028
1 condition1 sponsor7 locations
NCT07158398
Evaluate the Effect of Vimseltinib on the Pharmacokinetics of a BCRP and OATP1B1 Substrate
PHASE1Recruiting
20 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06810934
A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
PHASE1/PHASE2Recruiting
80 participants
Started: Oct 31, 2025 · Completed: Sep 30, 2029
2 conditions5 sponsors2 locations
NCT06594068
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
PHASE4Recruiting
16 participants
Started: Oct 31, 2025 · Completed: Aug 31, 2027
1 condition2 sponsors1 location
NCT07193511
Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
PHASE1/PHASE2Recruiting
355 participants
Started: Oct 31, 2025 · Completed: Sep 30, 2030
4 conditions1 sponsor1 location
NCT07179575
Study of LW231 in Participants With Chronic Hepatitis B
PHASE1/PHASE2Recruiting
270 participants
Started: Oct 31, 2025 · Completed: Nov 30, 2027
1 condition1 sponsor2 locations
NCT07181837
A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome
PHASE1/PHASE2Recruiting
12 participants
Started: Oct 31, 2025 · Completed: May 31, 2031
1 condition1 sponsor1 location
NCT07185776
A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events
PHASE2Recruiting
200 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2027
1 condition1 sponsor2 locations
NCT07042165
Treatment of Bile Acid Diarrhoea With Atorvastatin
PHASE4Recruiting
20 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2026
2 conditions4 sponsors1 location
NCT07087054
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
PHASE3Recruiting
141 participants
Started: Oct 31, 2025 · Completed: Jan 31, 2030
9 conditions1 sponsor10 locations
NCT06665594
Effect of TXA on Reducing Bruising After Filler Injection
PHASE2Recruiting
40 participants
Started: Oct 31, 2025 · Completed: Sep 30, 2026
3 conditions1 sponsor1 location
NCT07040566
A Trial of Varenicline for E-cigarette Cessation
PHASE2Recruiting
326 participants
Started: Oct 31, 2025 · Completed: Jan 31, 2029
3 conditions2 sponsors2 locations
NCT07104630
Pulmonary Rehabilitation in Advanced Lung Cancer Survivors
PHASE2Recruiting
85 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2028
4 conditions2 sponsors1 location
NCT07142044
Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)
PHASE1/PHASE2Recruiting
18 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2027
1 condition3 sponsors1 location
NCT07205107
Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris
N/ARecruiting
200 participants
Started: Oct 31, 2025 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT07197905
Restoring Iron Deficiency in POTS
PHASE2Recruiting
12 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2026
1 condition2 sponsors1 location
NCT07209904
Economic Evaluation of Mindline.sg
NARecruiting
300 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT06870760
Pre-malignant States to Hematologic Malignancies in Firefighters
N/ARecruiting
300 participants
Started: Oct 31, 2025 · Completed: Apr 30, 2027
6 conditions2 sponsors1 location
NCT06398847
Virtual Reality (VR) Self-Hypnosis Software
NARecruiting
25 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT07010159
Phase 2/3 Study of KPL-387 in Recurrent Pericarditis
PHASE2/PHASE3Recruiting
165 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2029
3 conditions2 sponsors4 locations
NCT06946550
Non-Ablative Laser to Treat Scarring Alopecia With Hair Follicle Gene Expression Analysis
NARecruiting
5 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2027
1 condition3 sponsors1 location
NCT06947928
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
PHASE2/PHASE3Recruiting
118 participants
Started: Oct 31, 2025 · Completed: Dec 30, 2032
1 condition1 sponsor8 locations
NCT06980948
Safety and Tolerability Study of ST-503 for Small Fiber Neuropathy-associated Refractory Pain
PHASE1Recruiting
27 participants
Started: Oct 31, 2025 · Completed: Jul 31, 2028
1 condition1 sponsor10 locations
NCT06859788
SPI-1005 for the Treatment of Meniere's Disease (Open Label)
PHASE3Recruiting
200 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2026
2 conditions1 sponsor5 locations
NCT07075198
Caesar Foot Take-Home Validation Testing
NARecruiting
18 participants
Started: Oct 31, 2025 · Completed: Aug 31, 2026
2 conditions5 sponsors1 location
NCT07216508
Liver Transplant CGM
N/ARecruiting
40 participants
Started: Oct 31, 2025 · Completed: Oct 5, 2027
3 conditions1 sponsor1 location
NCT06062888
FFP In Traumatic BRAin INjury (FIT-BRAIN) Trial
PHASE2/PHASE3Recruiting
357 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2029
1 condition8 sponsors1 location
NCT06787729
At Home Wearable Sensors and Smartphone for Stroke Survivors With Upper Limb Motor Challenges.
NARecruiting
50 participants
Started: Oct 31, 2025 · Completed: Jul 31, 2026
1 condition4 sponsors1 location